Business Parks & Science Centres



Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 43 44 45 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Novartis AG. (1/7/15). "Press Release: Novartis Collaborates with Intellia Therapeutics and Caribou Biosciences to Explore Making Medicines and Drug Discovery Tools with CRISPR Genome Editing technology". Basel. 2015-01-07
Addex Therapeutics S.A.. (1/7/15). "Press Release: Addex and NIAAA Enter Collaboration to Evaluate ADX71441 in Alcohol Use Disorder". Geneva. 2015-01-07
Evotec AG. (1/7/15). "Press Release: Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-term Collaboration". Hamburg. 2015-01-07
Genkyotex S.A.. (1/7/15). "Press Release: Genkyotex Raises CHF 20 Million ($21 Million)". Geneva & Archamps. 2015-01-07
Provendis GmbH. (1/6/15). "Pressemitteilung: Provendis und TVM Capital Life Science besiegeln strategische Partnerschaft". 2015-01-06
Gilead Sciences, Inc.. (1/6/15). "Press Release: Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases". Foster City, CA & Ludwigshafen & Heidelberg. 2015-01-06
Cytos Biotechnology AG. (1/6/15). "Press Release: Cytos Exclusively Licenses Its VLP Platform for the Treatment of Hepatitis B Infections to OnCore Biopharma". Schlieren. 2015-01-06
Pfizer Inc.. (1/5/15). "Press Release: Pfizer Acquires Redvax GmbH. Acquisition Provides Pfizer with a Preclinical CMV Vaccine Candidate". 2015-01-05
Bayer AG. (1/5/15). "Press Release: FDA Approves Bayer’s Gadavist (gadobutrol) Injection as the First Magnetic Resonance Contrast Agent for Pediatric Patients Less than 2 Years of Age [Not intended for U.S. and UK Media]". Leverkusen. 2015-01-05
BioMed X GmbH. (1/5/15). "Press Release: Boehringer Ingelheim and BioMed X Collaborate to Discover New Epigenetic Regulators of COPD". Heidelberg. 2015-01-05
Novartis AG. (1/1/15). "Press Release: Novartis Completes Divestment of Animal Health Business to Eli Lilly for USD 5.4 Billion". Basel. 2015-01-01
From »The Analytical Scientist« (Issue 23, December 2014). (12/14). "How to Get PR Right (by Marcus Lippold)". 2014-12-31
Novartis AG. (12/26/14). "Press Release: First in the World Regulatory Approval of Novartis' Cosentyx in Japan for Both Psoriasis and Psoriatic Arthritis". Basel. 2014-12-26
Novartis AG. (12/23/14). "Press Release: Alcon Treatment Travatan Receives EU Approval for Pediatric Glaucoma Patients". Basel. 2014-12-23
Sigma-Aldrich Corporation. (12/23/14). "Press Release: Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance". St. Louis, MO. 2014-12-23
Actelion Ltd.. (12/23/14). "Press Release: Actelion Submits US FDA New Drug Application for Selexipag (Uptravi) in Patients with Pulmonary Arterial Hypertension". Allschwil. 2014-12-23
Pieris Pharmaceuticals, Inc.. (12/23/14). "Press Release: Pieris Pharmaceuticals, Inc. Completes Private Placement, Raises $13.6M". Freising. 2014-12-23
Evotec AG. (12/22/14). "Press Release: Evotec and Ohio State to Collaborate on Novel Cancer Therapy". Hamburg. 2014-12-22
Evolva Holding S.A.. (12/22/14). "Press Release: Evolva Completes Share Sale Related to Allylix acquisition". Reinach. 2014-12-22
Basilea Pharmaceutica Ltd.. (12/22/14). "Press Release: Swissmedic Approves Basilea's Antibiotic Zevtera (ceftobiprole medocaril) for the Treatment of Pneumonia". Basel. 2014-12-22
Sartorius AG. (12/19/14). "Press Release: Sartorius to Sell Its Industrial Technologies Division to Minebea Co., Ltd.". Göttingen. 2014-12-19
Bina Technologies, Inc.. (12/19/14). "Press Release: Bina Technologies Acquired by Roche". Redwood City, CA. 2014-12-19
Markes International Ltd.. (12/19/14). "Press Release: Markes International Further Strengthens Its Product Marketing Expertise with New Appointment". Llantrisant. 2014-12-19
Roche. (12/19/14). "Press Release: Roche Provides Update on Phase III MARIANNE Study in People with Previously Untreated Advanced HER2-positive Breast Cancer". Basel. 2014-12-19
Roche. (12/19/14). "Press Release: Roche Provides Update on Gantenerumab Development Programme". Basel. 2014-12-19
Bruker Corporation. (12/19/14). "Press Release: Announcement of Bruker HMDB Metabolite Library to Accelerate the Accurate Mass Identification of Target Compounds in Clinical Metabolomics". Billerica, MA. 2014-12-19
Analytik Jena AG. (12/19/14). "Press Release: Analytik Jena Announces Group Figures for 2013/2014 Financial Year". Jena. 2014-12-19
MorphoSys AG. (12/19/14). "Press Release: MorphoSys’s Partner Roche Provides Update on Trial of Gantenerumab in Prodromal Alzheimer's Patients". 2014-12-19
Merck & Co., Inc.. (12/18/14). "Press Release: Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers". Kenilworth, NJ. 2014-12-18
Sartorius AG. (12/18/14). "Press Release: Sartorius Signs Long-term Syndicated Loan. Credit Volume of 400 Million Euros – International Bank Syndicate Led by BNP Paribas, Commerzbank and LBBW". Göttingen. 2014-12-18
Roche. (12/18/14). "Press Release: Roche Unveils MycoTOOL Real-Time PCR Kit Validation Report for Improved Quality Control of Biopharmaceutical Products". Rotkreuz. 2014-12-18
Roche. (12/18/14). "Press Release: Roche to Acquire Dutalys to Augment Development of Bi-specific Antibodies". Basel. 2014-12-18
Pieris Pharmaceuticals, Inc.. (12/18/14). "Press Release: Pieris Pharmaceuticals, Inc. Goes Public, Raises $12.2 Million. Completion of Alternative Public Offering in Which Pieris AG Becomes a Wholly-Owned Subsidiary of Pieris Pharmaceuticals, Inc.". Fre 2014-12-18
Evotec AG. (12/18/14). "Press Release: Achievement of Multiple Milestones in Evotec’s Drug Discovery Alliances". Hamburg. 2014-12-18
Shimadzu Corporation. (12/18/14). "Press Release: EMC Center Designated as TÜV Rheinland Japan Appointed Laboratory – Aiming to Become an Even More Reliable Testing Laboratory". 2014-12-18
Lonza Group Ltd.. (12/18/14). "Press Release: Lonza and AdAlta Announce a Strain Development Contract for Novel Biologic Therapeutics". Basel & Melbourne. 2014-12-18
Carl Zeiss AG. (12/17/14). "Press Release: Zeiss Asserts Its Position In Difficult Environment. Revenue and Earnings above the Previous Year – Continued High Level of Expenditure on Research and Development". Stuttgart. 2014-12-17
Humedics GmbH. (12/17/14). "Press Release: BioMedInvest-II LP Joins Humedics Series C Financing and Increases Financing Round to 7 Million Euro". Berlin. 2014-12-17
Epigenomics AG. (12/17/14). "Press Release: First Patients Enrolled in Epigenomics’ Epi proColon ADMIT Study". Berlin & Germantown, MD. 2014-12-17
Evolva Holding S.A.. (12/17/14). "Press Release: Evolva Sells EV-035 Series to Emergent BioSolutions". Reinach. 2014-12-17
Addex Therapeutics S.A.. (12/17/14). "Press Release: Addex Amends mGlu2PAM Collaboration Agreement and Receives USD757,000". Geneva. 2014-12-17
Sanofi S.A.. (12/17/14). "Press Release: Merial Acquires Two Major Equine Health Products from Bayer". Paris. 2014-12-17
Varian Medical Systems, Inc.. (12/17/14). "Press Release: Varian Medical Systems Announces Intention to Acquire MeVis Medical Solutions AG through a Public Tender Offer". Palo Alto, CA. 2014-12-17
MeVis Medical Solutions AG. (12/17/14). "Press Release: Executive Board and Supervisory Board welcome public takeover offer of VMS Deutschland Holdings GmbH [Ad hoc announcement]". Bremen. 2014-12-17
Fluidigm Corporation. (12/17/14). "Press Release: Making Single-Cell Biology Work. New Collaboration Between EMBL-EBI, the Wellcome Trust Sanger Institute and Fluidigm Keeps Research and Technology on the Cutting-Edge of Single-Cell Genomics". South San 2014-12-17
H. Lundbeck A/S. (12/17/14). "Press Release: Lundbeck Discontinues Further Development of Desmoteplase, 2014 Profit Guidance Range Narrowed". 2014-12-17
Protagen AG. (12/16/14). "Press Release: Protagen Successfully Closes New Financing Round". 2014-12-16
Sartorius AG. (12/16/14). "Press Release: Sartorius Supervisory Board Extends Appointment of the Group’s CEO Joachim Kreuzburg". Göttingen. 2014-12-16
Roche. (12/16/14). "Press Release: Roche Launches PCR Molecular Diagnostic System for Point of Care Environment". Pleasanton, CA. 2014-12-16
Evolva Holding S.A.. (12/16/14). "Press Release: Evolva Completes Allylix Acquisition". Reinach. 2014-12-16
Novartis AG. (12/16/14). "Press Release: Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly, a Rare and Life-threatening Hormonal Disorder". Basel. 2014-12-16
MorphoSys AG. (12/15/14). "Press Release: MorphoSys's MOR208 Program Receives Positive Opinion for Orphan Medicinal Product Designation from EMA for DLBCL". 2014-12-15
Roche. (12/15/14). "Press Release: Roche Expands CE-IVD Claims for Organ and Tissue Testing for Next Generation Blood Screening Assays". Pleasanton, CA. 2014-12-15
Boehringer Ingelheim. (12/15/14). "Press Release: First Trial of a Novel Oral Anticoagulant Starts in Prevention of Recurrent Stroke Due to a Blood Clot of Undetermined Source [For Non-US/Non-UK/Non-Canadian Media]". Ingelheim. 2014-12-15
Annexon Biosciences. (12/15/14). "Press Release: Annexon Bioscience Closes $34M Series". Redwood City, CA. 2014-12-15
Sygnis AG. (12/12/14). "Press Release: Sygnis AG Successfully Completes Rights Offering and Private Placement". Heidelberg. 2014-12-12
Deutsche Biotech Innovativ AG. (12/12/14). "Pressemitteilung: Kapitalerhöhung beschlossen und bereits erfolgreich platziert". Hennigsdorf. 2014-12-12
Roche. (12/12/14). "Press Release: Changes in Roche Board of Directors and Enlarged Corporate Executive Committee". Basel. 2014-12-12
Dentons. (12/12/14). "Press Release: Dentons Enhances German Compliance Offering with Two New Hires". Basel. 2014-12-12
Pieris AG. (12/11/14). "Press Release: Pieris Initiates Phase I Clinical Trial for Anticalin to Treat Anemia". Freising. 2014-12-11
BioRN Cluster Management GmbH. (12/11/14). "Press Release: Biotech-Cluster Rhine-Neckar (BioRN) Leads InnoLife Consortium to Success in the Competition Healthy Living and Active Ageing of the European Institute for Innovation and Technology (EIT)". Heide 2014-12-11
Anergis S.A.. (12/11/14). "Press Release: Anergis Starts Phase II Dose Ranging Trial with Birch Pollen Allergy Vaccine AllerT. Dose Assessment for Upcoming Phase III Trial". Epalinges. 2014-12-11
Evolva Holding S.A.. (12/11/14). "Press Release: Evolva Announces Multi-product Collaboration with Takasago". Reinach. 2014-12-11
Danaher Corporation. (12/11/14). "Press Release: Danaher Completes Acquisition Of Nobel Biocare". Washington, D.C.. 2014-12-11
CovalX AG. (12/11/14). "Press Release: CovalX HM3 in Shimadzu Demo Laboratory in Kyoto, Japan". 2014-12-11
Noxxon Pharma AG. (12/10/14). "Press Release: New Addition to Noxxon Supervisory Board Brings Significant US Public Market Expertise. Don deBethizy Joins Noxxon Supervisory Board". Berlin & Boston, MA. 2014-12-10
Roche. (12/10/14). "Press Release: Roche Diagnostics Purchases Tissue Dissection Technology from AvanSci Bio". Pleasanton, CA. 2014-12-10
BioRegio STERN Management GmbH. (12/10/14). "Press Release: Newly Established CeMeT GmbH in Tübingen Analysing the Metagenome of Microorganisms in the Human Body". 2014-12-10
Roche. (12/10/14). "Press Release: Roche’s Preeclampsia Test Helps to Predict this Life-threatening Condition in Pregnant Women at Risk. New Data Demonstrate High Prognostic Value of Elecsys Blood Test". Basel. 2014-12-10
Lonza Group Ltd.. (12/10/14). "Press Release: Lonza Executes Collaboration Agreements with Two Innovation Clusters". Basel. 2014-12-10
Selexis S.A.. (12/9/14). "Press Release: Symphogen A/S Licenses the Selexis SUREtechnology Expression Platform and Cell Line". Geneva. 2014-12-09
Heraeus Medical GmbH. (12/9/14). "Press Release: Heraeus Medical GmbH Signs Exclusive License and Development Agreement with Locate Therapeutics for Orthopaedic Applications". 2014-12-09
4SC AG. (12/9/14). "Press Release: 4SC Reports Positive Topline Data from Clinical Phase I Trial with 4SC-205 in Cancer Patients Using Novel Continuous Dosing Scheme". Planegg-Martinsried. 2014-12-09
Bayer AG. (12/9/14). "Press Release: Bayer and DNDi Sign First Agreement to Develop an Innovative Oral Treatment for Human River Blindness". Berlin & Geneva. 2014-12-09
Sygnis AG. (12/8/14). "Press Release: Sygnis AG Signs Initial Non-exclusive Distribution Agreement for Its First Proprietary Product with BioCat GmbH. TruePrime Single Cell WGA Kit to Be Launched early 2015". Madrid & Heidelberg. 2014-12-08
Definiens AG. (12/8/14). "Press Release: Definiens Releases Tissue Studio 4.0 for Quantitative Digital Pathology". Munich. 2014-12-08
Epigenomics AG. (12/8/14). "Press Release: Epigenomics and BioChain Announce Approval of Epi proColon in China". Berlin et al.. 2014-12-08
Carl Zeiss Meditec AG. (12/8/14). "Press Release: Annual Statement – Carl Zeiss Meditec Posts Slight Revenue Growth. Currency Effects and Regional Variations in Business Burden Results". Jena. 2014-12-08
Affimed N.V.. (12/8/14). "Press Release: Affimed Presents Final Data for AFM13 Phase 1 Trial at ASH. Data Confirm Clinical Activity in Relapsed/Refractory Hodgkin Lymphoma Patients". Heidelberg. 2014-12-08
MorphoSys AG. (12/8/14). "Press Release: MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at American Society of Hematology Meeting. DLBCL and FL Identified as Particularly Promising Indications". 2014-12-08
Pieris AG. (12/8/14). "Press Release: Pieris Achieves GLP Tox Milestone Payment in Daiichi Sankyo Collaboration to Develop Anticalin Therapeutics". Freising. 2014-12-08
Roche. (12/8/14). "Press Release: Roche Launches Next-generation Viral Load Testing Assays for New Molecular Diagnostic Platforms in Markets Accepting the CE Mark". Basel. 2014-12-08
Proteo Biotech AG. (12/5/14). "Press Release: Proteo Biotech AG Expands Management Board". Irvine, CA & Kiel. 2014-12-05
Sigma-Aldrich Corporation. (12/5/14). "Press Release: Sigma-Aldrich Stockholders Approve Acquisition By Merck KGaA". St. Louis, MO. 2014-12-05
Metabolomic Discoveries GmbH. (12/5/14). "Press Release: KWS and Metabolomic Discoveries Sign Research Agreement". Einbeck & Potsdam. 2014-12-05
Roche. (12/5/14). "Press Release: Roche to Present Clinical Data from Six Different Medicines at ASH". Basel. 2014-12-05
Basilea Pharmaceutica Ltd.. (12/5/14). "Press Release: Basilea Announces Launch of Antibiotic Zevtera® (ceftobiprole medocaril) in Germany. First Commercial Launch". Basel. 2014-12-05
Molecular Partners AG. (12/5/14). "Press Release: Total Offer Size of IPO Reaches CHF 106.2 Million after Partial Exercise of IPO Over-allotment Option". Zürich-Schlieren. 2014-12-05
Sigma-Aldrich Corporation. (12/4/14). "Press Release: Sigma-Aldrich Life Sciences Licenses Foundational CRISPR Patents from Broad Institute". St. Louis, MO. 2014-12-04
Qiagen N.V.. (12/4/14). "Press Release: Qiagen to Distribute Altona Diagnostic’s RealStar Ebolavirus RT-PCR Kit 1.0, Recently Authorized by the FDA for Emergency Use". Hilden & Germantown, MD. 2014-12-04
Ionicon Analytik GmbH. (12/4/14). "Press Release: Fast GC Add-on for Ionicon PTR-TOF Instruments. Gas Chromatographic Separation Now Combined with Real-time Trace Gas Analysis". Innsbruck. 2014-12-04
Anergis S.A.. (12/3/14). "Press Release: Anergis Closes Series B Financing Round Totaling CHF 14.5 Million". Epalinges. 2014-12-03
Sigma-Aldrich Corporation. (12/3/14). "Press Release: Sigma-Aldrich Launches Comprehensive Flavors and Fragrances Standards Portfolio Aimed at Food & Beverage and Cosmetics Industries". St. Louis, MO. 2014-12-03
Amgen Inc.. (12/3/14). "Press Release: FDA Approves Blincyto (blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia". Thousand Oaks, CA & South San Francisco, CA. 2014-12-03
GATC Biotech AG. (12/3/14). "Press Release: GATC Biotech Lifts Next Generation Sequencing Services with NGSelect to the Next Level. Customers Benefit from a Modular Set-up Which Meets Frequent Scientific Needs". Constance. 2014-12-03
VTU Technology GmbH. (12/3/14). "Press Release: VTU Technology and RCT Announce Partnership". Tucson, AZ & Grambach. 2014-12-03
Actelion Ltd.. (12/2/14). "Press Release: Actelion Submits Selexipag (Uptravi) for EMA Marketing Authorisation in Patients with Pulmonary Arterial Hypertension". Allschwil. 2014-12-02
Roche. (12/2/14). "Press Release: Roche Acquires Ariosa Diagnostics and Enters the Non-invasive Prenatal Test (NIPT) and Cell-free DNA Testing Services Markets". Basel. 2014-12-02
High-Tech Gründerfonds Management GmbH. (12/2/14). "Press Release: HTGF Portfolio Company Ayoxxa Biosystems Extends Series B. Andreas Richter New CFO of Ayoxxa". Cologne & Bonn. 2014-12-02
Enamine Ltd.. (12/2/14). "Press Release: BioVersys and Enamine Announce Extension of Drug Discovery Collaboration to Address Multidrug-Resistant Bacterial Infections". Kiev & Basel. 2014-12-02
next pagenext page 1 2 3 ... 43 44 45 ... 97 98 99  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSUS] – The Business Web Portal 600x60px

» top